Icad, Inc. operates in the Surgical and medical instruments sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Icad with three other
companies in this sector in the United States:
MGC Diagnostics Corporation
sales of $37.47 million
Utah Medical Products, Inc.
Inovio Pharmaceuticals Inc
of which 100%
was Drug & Gene Delivery).
Icad reported sales of $41.55 million
December of 2015.
decrease of 5.4%
versus 2014, when the company's sales were $43.92 million.
Contributing to the drop in overall sales was the 11.9% decline
in Therapy, from $25.32 million to $22.31 million.
However, these declines were partially offset by the increase in sales of
Detection (up 3.4% to $19.24 million)